15 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2034. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2034
Next term end
10
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2034 · High confidence
Also notable
Ends Jun 2034 · High confidence
Also notable
Ends Oct 2034 · High confidence
Therapeutic Compounds and Uses Thereof
US 10,398,703
A family of 5 related applications built on the 2019 grant. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Urea Derivatives and Uses Thereof
US 9,212,145
The largest patent family in this portfolio, 9 related applications, renewed at every maintenance window due so far. Protection runs to 2034.
Crystalline Forms of Therapeutic Compounds and Uses Thereof
US 10,160,765
A family of 6 related applications built on the 2018 grant. Protection runs to 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 11 to 25, 2026 · next Dec 11
- 2 fees due Jan 2 to 16, 2027 · next Jan 2
- 2 fees due Feb 1 to 27, 2027 · next Feb 1
- 1 fee due Mar 3, 2027The maintenance fee for Therapeutic Compounds and Uses Thereof (US 10,398,703) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 1 fee due Jun 15, 2027The maintenance fee for Urea Derivatives and Uses Thereof (US 9,212,145) comes due Jun 15, 2027. Unpaid by Dec 15, 2027, it lapses early.
- 1 fee due Jul 28, 2027The maintenance fee for Novel Compounds and Uses Thereof (US 10,544,151) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Crystalline Forms of Therapeutic Compounds and Uses Thereof (US 10,618,906) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Crystalline Forms of Therapeutic Compounds and Uses Thereof (2017) | 3 in force | to Oct 2034 |
| Urea Derivatives and Uses Thereof | 3 in force | to Jun 2034 |
| Novel Compounds and Uses Thereof | 2 in force | to May 2034 |
| Crystalline Forms of Therapeutic Compounds and Uses Thereof (2017) | 1 in force | to Sep 2037 |
| Crystalline Forms of Therapeutic Compounds and Uses Thereof (2017) | 1 in force | to Sep 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,398,703 | Therapeutic Compounds and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,285,991 | Therapeutic Compounds and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,351,570 | Novel Compounds and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,544,151 | Novel Compounds and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,212,145 | Urea Derivatives and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,174,022 | 1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,316,022 | Urea Derivatives and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,329,280 | Urea Derivatives and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,160,765 | Crystalline Forms of Therapeutic Compounds and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,618,906 | Crystalline Forms of Therapeutic Compounds and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 15: 29 patents ended · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.